219 related articles for article (PubMed ID: 33405390)
21. Establishment of a Prognostic Nomogram for Lung Adenocarcinoma with Brain Metastases.
Huang Z; Tong Y; Tian H; Zhao C
World Neurosurg; 2020 Sep; 141():e700-e709. PubMed ID: 32531436
[TBL] [Abstract][Full Text] [Related]
22. Prognostic Value of the Site of Distant Metastasis and Surgical Interventions in Metastatic Gastric Cancer: A Population-Based Study.
Li Y; Xie D; Chen X; Hu T; Lu S; Han Y
Technol Cancer Res Treat; 2020; 19():1533033820964131. PubMed ID: 33111644
[TBL] [Abstract][Full Text] [Related]
23. A clinical model to predict distant metastasis in patients with superficial gastric cancer with negative lymph node metastasis and a survival analysis for patients with metastasis.
Chen J; Wu L; Zhang Z; Zheng S; Lin Y; Ding N; Sun J; Shi L; Xue M
Cancer Med; 2021 Feb; 10(3):944-955. PubMed ID: 33350173
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic and prognostic nomograms for bone metastasis in hepatocellular carcinoma.
Hu C; Yang J; Huang Z; Liu C; Lin Y; Tong Y; Fan Z; Chen B; Wang C; Zhao CL
BMC Cancer; 2020 Jun; 20(1):494. PubMed ID: 32487048
[TBL] [Abstract][Full Text] [Related]
25. Sites of distant metastases and overall survival in ovarian cancer: A study of 1481 patients.
Deng K; Yang C; Tan Q; Song W; Lu M; Zhao W; Lou G; Li Z; Li K; Hou Y
Gynecol Oncol; 2018 Sep; 150(3):460-465. PubMed ID: 30001833
[TBL] [Abstract][Full Text] [Related]
26. Frequency and prognosis of metastasis to liver, lung, bone and brain from Merkel cell carcinoma.
Xia YJ; Cao DS; Zhao J; Zhu BZ; Xie J
Future Oncol; 2020 Jun; 16(16):1101-1113. PubMed ID: 32314598
[No Abstract] [Full Text] [Related]
27. Nomograms to predict lung metastasis probability and lung metastasis subgroup survival in malignant bone tumors.
Wang J; Fan Y; Xia L
Future Oncol; 2021 Feb; 17(6):649-661. PubMed ID: 33464127
[TBL] [Abstract][Full Text] [Related]
28. Subdivision of M1 Stage for De Novo Metastatic Breast Cancer to Better Predict Prognosis and Response to Primary Tumor Surgery.
Lin C; Wu J; Ding S; Goh C; Andriani L; Lu S; Shen K; Zhu L
J Natl Compr Canc Netw; 2019 Dec; 17(12):1521-1528. PubMed ID: 31805535
[TBL] [Abstract][Full Text] [Related]
29. Comparison of survival of patients with metastases from known versus unknown primaries: survival in metastatic cancer.
Riihimäki M; Thomsen H; Hemminki A; Sundquist K; Hemminki K
BMC Cancer; 2013 Jan; 13():36. PubMed ID: 23356713
[TBL] [Abstract][Full Text] [Related]
30. Risk factors for metastasis and poor prognosis of Ewing sarcoma: a population based study.
Shi J; Yang J; Ma X; Wang X
J Orthop Surg Res; 2020 Mar; 15(1):88. PubMed ID: 32131863
[TBL] [Abstract][Full Text] [Related]
31. [Analysis of prognostic factors in 68 patients with cancer of unknown primary site].
Kou XG; Liang DL; Zhang QQ; Li XR; Zhao YZ; Gu JF; Lu P
Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):783-6. PubMed ID: 22335913
[TBL] [Abstract][Full Text] [Related]
32. Prognostic Significance of Sites of Visceral Metastatic Disease in Prostate Cancer: A Population-based Study of 12,180 Patients.
Budnik J; Suri J; Bates JE; Bylund KC; Milano MT
Clin Genitourin Cancer; 2019 Aug; 17(4):260-267. PubMed ID: 31101579
[TBL] [Abstract][Full Text] [Related]
33. Biological characteristics and treatment outcomes of metastatic or recurrent neuroendocrine tumors: tumor grade and metastatic site are important for treatment strategy.
Kim SJ; Kim JW; Han SW; Oh DY; Lee SH; Kim DW; Im SA; Kim TY; Seog Heo D; Bang YJ
BMC Cancer; 2010 Aug; 10():448. PubMed ID: 20731845
[TBL] [Abstract][Full Text] [Related]
34. Impact of PET/CT on clinical management in patients with cancer of unknown primary-a PET/CT registry study.
Reinert CP; Sekler J; la Fougère C; Pfannenberg C; Gatidis S
Eur Radiol; 2020 Mar; 30(3):1325-1333. PubMed ID: 31728688
[TBL] [Abstract][Full Text] [Related]
35. Worse characteristics can predict survival effectively in bilateral primary breast cancer: A competing risk nomogram using the SEER database.
Shen K; Yao L; Wei J; Luo Z; Yu W; Zhai H; Wang J; Chen L; Fu D
Cancer Med; 2019 Dec; 8(18):7890-7902. PubMed ID: 31663683
[TBL] [Abstract][Full Text] [Related]
36. Clinical correlates and prognostic value of different metastatic sites in patients with malignant melanoma of the skin: a SEER database analysis.
Abdel-Rahman O
J Dermatolog Treat; 2018 Mar; 29(2):176-181. PubMed ID: 28745581
[TBL] [Abstract][Full Text] [Related]
37. How do organ-specific metastases affect prognosis and surgical treatment for patients with metastatic upper tract urothelial carcinoma: first evidence from population based data.
Dong F; Fu H; Shi X; Shen Y; Xu T; Gao F; Wang X; Zhong S; Ding Q; Shen Z; Chen S
Clin Exp Metastasis; 2017 Dec; 34(8):467-477. PubMed ID: 29500709
[TBL] [Abstract][Full Text] [Related]
38. Development and validation of a nomogram to predict overall survival for patients with metastatic renal cell carcinoma.
Zheng W; Zhu W; Yu S; Li K; Ding Y; Wu Q; Tang Q; Zhao Q; Lu C; Guo C
BMC Cancer; 2020 Nov; 20(1):1066. PubMed ID: 33148204
[TBL] [Abstract][Full Text] [Related]
39. The prognostic analysis of different metastatic patterns in advanced liver cancer patients: A population based analysis.
Chen J
PLoS One; 2018; 13(8):e0200909. PubMed ID: 30102707
[TBL] [Abstract][Full Text] [Related]
40. Pattern and prognosis of distant metastases in nasopharyngeal carcinoma: A large-population retrospective analysis.
Qu W; Li S; Zhang M; Qiao Q
Cancer Med; 2020 Sep; 9(17):6147-6158. PubMed ID: 32649056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]